Literature DB >> 9190996

Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues.

A C Han1, A Peralta-Soler, K A Knudsen, M J Wheelock, K R Johnson, H Salazar.   

Abstract

The differential diagnosis of pleural mesotheliomas and lung adenocarcinomas presents a continued challenge in the practice of surgical pathology. Paraffin immunohistochemistry (IHC) using different panels of antibodies can be helpful in some cases, but, as yet, no antigen is expressed specifically in mesotheliomas nor in adenocarcinomas. Using well characterized monoclonal antibodies (MAb) that recognized distinct mesenchymal and epithelial adhesion proteins, N-cadherin (13A9 MAb) and E-cadherin (E9 MAb), respectively, we found previously that in frozen-section IHC mesotheliomas and adenocarcinomas had distinct cadherin phenotypes: mesotheliomas were positive for N-cadherin, and lung adenocarcinomas were positive for E-cadherin. Using antigen-retrieval methods, we successfully extended our study to formalin-fixed, paraffin-embedded tissue sections. Tumors from 28 patients (14 originally diagnosed as mesotheliomas, and 14 diagnosed as adenocarcinomas) were stained with 13A9 MAb and E9 MAb. Review of hematoxylin-eosin sections excluded from analysis one case previously diagnosed as mesothelioma, which represented a hemangiopericytoma. Of the remaining 27 cases, 12 of 13 mesotheliomas were positive for N-cadherin and negative for E-cadherin. The exception was a multifocal microscopic papillary tumor of apparent mesothelial origin, which was negative for both N-cadherin and E-cadherin. Conversely, 13 of 14 adenocarcinomas were E-cadherin positive and N-cadherin negative except for one adenocarcinoma with focal N-cadherin expression. One case of a poorly differentiated adenocarcinoma invading skeletal muscle was negative for both 13A9 and E9. These studies confirmed the utility of the cadherin antibodies in distinguishing pleural mesotheliomas from lung adenocarcinomas. The reactivity of the cadherin-specific antibodies with antigens in paraffin sections make them powerful and reliable markers in the practice of diagnostic surgical pathology.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9190996     DOI: 10.1016/s0046-8177(97)90171-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  16 in total

1.  Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings.

Authors:  B Risberg; B Davidson; H P Dong; J M Nesland; A Berner
Journal:  J Clin Pathol       Date:  2000-07       Impact factor: 3.411

2.  Immunophenotypings of malignant epithelial mesothelioma and their roles in the differential diagnosis.

Authors:  Qiurong Ruan; Yuchang Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

3.  Establishment of permanent cell lines purified from human mesothelioma: morphological aspects, new marker expression and karyotypic analysis.

Authors:  Marie-Marthe Philippeaux; Jean-Claude Pache; Sophie Dahoun; Marc Barnet; John-Henri Robert; Jacques Mauël; Anastase Spiliopoulos
Journal:  Histochem Cell Biol       Date:  2004-09-15       Impact factor: 4.304

4.  Expression of P-cadherin identifies prostate-specific-antigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas. Implications for prostate cancer biology.

Authors:  A P Soler; G D Harner; K A Knudsen; F X McBrearty; E Grujic; H Salazar; A C Han; A A Keshgegian
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

5.  Reduced expression of E-cadherin in human non-small cell lung carcinoma.

Authors:  Na-Hye Myong
Journal:  Cancer Res Treat       Date:  2004-02-29       Impact factor: 4.679

6.  The clinical behavior of mixed ductal/lobular carcinoma of the breast: a clinicopathologic analysis.

Authors:  Aparna Suryadevara; Lakshmi P Paruchuri; Nassim Banisaeed; Gary Dunnington; Krishna A Rao
Journal:  World J Surg Oncol       Date:  2010-06-21       Impact factor: 2.754

7.  Genomic events associated with progression of pleural malignant mesothelioma.

Authors:  Sergey V Ivanov; Jeremy Miller; Robert Lucito; Chunlao Tang; Alla V Ivanova; Jianming Pei; Michele Carbone; Christina Cruz; Amanda Beck; Craig Webb; Daisuke Nonaka; Joseph R Testa; Harvey I Pass
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

8.  Cytoplasmic redistribution of E-cadherin-catenin adhesion complex is associated with down-regulated tyrosine phosphorylation of E-cadherin in human bronchopulmonary carcinomas.

Authors:  B Nawrocki; M Polette; J Van Hengel; J M Tournier; F Van Roy; P Birembault
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

9.  Expression of cancer-associated molecules in malignant mesothelioma.

Authors:  Ben Davidson
Journal:  Biomark Insights       Date:  2007-05-30

10.  N-cadherin expression in malignant germ cell tumours of the testis.

Authors:  Felix Bremmer; Bernhard Hemmerlein; Arne Strauss; Peter Burfeind; Paul Thelen; Heinz-Joachim Radzun; Carl Ludwig Behnes
Journal:  BMC Clin Pathol       Date:  2012-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.